Emerging Nanomedicines for Diabetes Treatment

In this short video extract Professor Phei Er Saw, Executive Editor, BIOI, introduces a presentation from Dr Jaison Jeevanandam, Centro De Quimica Da Madeira, University of Madeira, Portugal, on Emerging Nanomedicines for Diabetes Treatment:

Emerging Nanomedicines for Diabetes Treatment

Diabetes mellitus has been a threat to humans for many years. Amongst the different diabetes types, type 2 diabetes mellitus is the most common, and this is due to drastic changes in human lifestyle such as lack of exercise, stressful life and so on. There are many conventional treatment methods available for type 2 diabetes mellitus. However, most of these methods are curative and are only applicable when the patient is highly symptomatic. Effective treatment strategies should be geared towards interfering with cellular and bio molecular mechanisms associated with the development and sustenance of the disease. In recent years, research into the medical potential of nanoparticles has been a major endeavor within the pharmaceutical industries. This presentation Dr Jeevanandam highlights the application of potential nano-formulations in the treatment of type 2 diabetes mellitus.

A full video of this session from the webinar series, Medical and Industrial Integration and Precision Theranostics, held in August 2021, can be viewed at:

Medical and Industrial Integration and Precision Theranostics

Session details as follows:

Session	Topic	Speaker
1	Emerging Nanomedicines for Diabetes Treatment: 00:00.30 – 00.32.10	Jaison Jeevanandam, Centro De Quimica Da Madeira, University of Madeira, Portugal
2	Multidisciplinary Team Approach: The Crux of Breast Cancer Management in the New Normal: 00.32.11 – 01:05.30	Mok Chi Wei, Changi General Hospital. Singapore
3	Applications of Artificial Intelligence Based Image Processing: 01:05.31 – 01:45.06	Houari Sabarin, SkymatiX, Inc., Tokyo, Japan
4	Road to Cardiac Regeneration: 01:45.07 – 02.21.36	Tan Jun Jie, Universiti Sains Malaysia